Skip to main content
OpenTrials

Clinical trial condition

GastroEsophageal Cancer

Explore clinical trials studying GastroEsophageal Cancer. Study availability and eligibility vary by location and protocol.

62 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

GastroEsophageal Cancer trial results

Completed

A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies

NCT03629756

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +76 more
Locations
  • Scottsdale Healthcare Hospitals dba HonorHealth Scottsdale, Arizona, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • Rocky Mountain Cancer Centers (Midtown) Denver, Colorado, United States
View all 15 locations
View Trial Details
Completed

A Study to Evaluate Immunotherapy Combinations in Participants With Gastrointestinal Malignancies

NCT03720678

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +10 more
Locations
  • Arizona Clinical Research Center Tucson, Arizona, United States
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Maryland Oncology Hematology Rockville, Maryland, United States
View all 24 locations
View Trial Details
Completed

APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction Cancers

NCT03165994

Conditions
Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +8 more
Locations
  • University of Arizona Tucson, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • MedStar Georgetown University Hospital (MGUH) Washington D.C., District of Columbia, United States
View Trial Details
Completed

TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers

NCT03829436

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +58 more
Locations
  • University of California - San Francisco San Francisco, California, United States
  • Miami Cancer Institute Miami, Florida, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
View Trial Details
Completed

Early Palliative Care in Patients With Metastatic Upper Gastrointestinal Cancers Treated With First-line Chemotherapy

NCT02853474

Conditions
Bile Duct Cancer, Bile Duct Diseases, Bile Duct Neoplasms, +21 more
Locations
  • Institut de cancérologie de l'Ouest-site PAUL Angers, France
  • CH de Béthune Beuvry, France
  • Centre Hospitalier Boulogne sur Mer Boulogne-sur-Mer, France
  • Centre François Baclesse, Caen Caen, France
View all 20 locations
View Trial Details
Completed

A Study of EDP1503 in Patients With Colorectal Cancer, Breast Cancer, and Checkpoint Inhibitor Relapsed Tumors

NCT03775850

Conditions
Adenocarcinoma, Bladder Cancer, Breast Diseases, +35 more
Locations
  • Highlands Oncology Group Rogers, Arkansas, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Stephenson Cancer Center Oklahoma City, Oklahoma, United States
  • Tennessee Oncology, PLLC Chattanooga, Tennessee, United States
View Trial Details

Related conditions